BIOMAT Database Logo BIOMAT Database Logo

Vasoactive intestinal peptide prevents PKCε-induced intestinal epithelial barrier disruption during EPEC infection. 2015

V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Child and Family Research Institute, British Columbia Children's Hospital, Vancouver, British Columbia, Canada; Division of Gastroenterology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada; and.

We previously showed that vasoactive intestinal peptide (VIP) protects against bacterial pathogen-induced epithelial barrier disruption and colitis, although the mechanisms remain poorly defined. The aim of the current study was to identify cellular pathways of VIP-mediated protection with use of pharmacological inhibitors during enteropathogenic Escherichia coli (EPEC) infection of Caco-2 cell monolayers and during Citrobacter rodentium-induced colitis. EPEC-induced epithelial barrier disruption involved the PKC pathway but was independent of functional cAMP, Rho, and NF-κB pathways. VIP mediated its protective effects by inhibiting EPEC-induced PKC activity and increasing expression of the junctional protein claudin-4. Short-term treatment with TPA, which is known to activate PKC, was inhibited by VIP pretreatment, while PKC degradation via long-term treatment with TPA mimicked the protective actions of VIP. Immunostaining for specific PKC isotypes showed upregulated expression of PKCθ and PKCε during EPEC infection. Treatment with specific inhibitors revealed a critical role for PKCε in EPEC-induced barrier disruption. Furthermore, activation of PKCε and loss of barrier integrity correlated with claudin-4 degradation. In contrast, inhibition of PKCε by VIP pretreatment or the PKCε inhibitor maintained membrane-bound claudin-4 levels, along with barrier function. Finally, in vivo treatment with the PKCε inhibitor protected mice from C. rodentium-induced colitis. In conclusion, EPEC infection increases intracellular PKCε levels, leading to decreased claudin-4 levels and compromising epithelial barrier integrity. VIP inhibits PKCε activation, thereby attenuating EPEC-induced barrier disruption.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003092 Colitis Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER. Colitides
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
October 2009, American journal of physiology. Gastrointestinal and liver physiology,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
1,25-Dihydroxyvitamin D3 prevents toluene diisocyanate-induced airway epithelial barrier disruption.
July 2015, International journal of molecular medicine,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Allicin Improves Intestinal Epithelial Barrier Function and Prevents LPS-Induced Barrier Damages of Intestinal Epithelial Cell Monolayers.
January 2022, Frontiers in immunology,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Cathelicidin-BF ameliorates lipopolysaccharide-induced intestinal epithelial barrier disruption in rat.
May 2016, Life sciences,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Disruption of the optic pathway during development affects vasoactive intestinal peptide mRNA expression.
November 1989, The New biologist,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Active immunization against vasoactive intestinal peptide prevents photo-induced prolactin secretion in turkeys.
October 1996, General and comparative endocrinology,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Activation of muscarinic receptors prevents TNF-α-mediated intestinal epithelial barrier disruption through p38 MAPK.
July 2017, Cellular signalling,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Editorial: Intestinal epithelial barrier disruption by enteric pathogens.
January 2023, Frontiers in cellular and infection microbiology,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation.
October 1997, The American journal of physiology,
V Morampudi, and V S Conlin, and U Dalwadi, and X Wu, and K C Marshall, and C Nguyen, and B A Vallance, and K Jacobson
Passage of vasoactive intestinal peptide across the blood-brain barrier.
March 2003, Peptides,
Copied contents to your clipboard!